Patents by Inventor Peter T. Lassota

Peter T. Lassota has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of EDG Receptor Binding Agents in Cancer
    Publication number: 20140303257
    Abstract: Provided is a method for treating solid tumors, e.g tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.
    Type: Application
    Filed: June 23, 2014
    Publication date: October 9, 2014
    Applicant: Novartis AG
    Inventors: Thomas Baumruker, Volker Brinkmann, Kenneth Richard La Montagne, Peter T. Lassota, Diane Mechtcheriakova, Jeanette Majorie Wood
  • USE OF EDG RECEPTOR BINDING AGENTS IN CANCER
    Publication number: 20090209495
    Abstract: Provided is a method for treating solid tumors, e.g. tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.
    Type: Application
    Filed: April 9, 2009
    Publication date: August 20, 2009
    Inventors: Thomas Baumruker, Volker Brinkmann, Kenneth Richard La Montagne, Peter T. Lassota, Diana Mechtcheriakova, Jeanette Marjorie Wood